(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release →
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Akagera Medicines, Belen Calvo Uyarra, Ebola, EIB Global, HIV, investment, Lassa fever, Michael Fairbanks, partnership, Regis Rugemanshuro, Rwanda, sustainability, Thomas Östros, tuberculosis, vaccine, wellness